Intellia Therapeutics Inc (NTLA)
21.57
+0.25
(+1.17%)
USD |
NASDAQ |
Apr 19, 16:00
21.45
-0.12
(-0.56%)
After-Hours: 20:00
Intellia Therapeutics Cash and Short Term Investments (Quarterly): 912.22M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 912.22M |
| September 30, 2023 | 854.79M |
| June 30, 2023 | 908.07M |
| March 31, 2023 | 933.54M |
| December 31, 2022 | 1.193B |
| September 30, 2022 | 828.19M |
| June 30, 2022 | 874.28M |
| March 31, 2022 | 855.25M |
| December 31, 2021 | 748.69M |
| September 30, 2021 | 798.27M |
| June 30, 2021 | 529.02M |
| March 31, 2021 | 584.06M |
| December 31, 2020 | 597.37M |
| September 30, 2020 | 407.95M |
| June 30, 2020 | 436.80M |
| March 31, 2020 | 250.26M |
| December 31, 2019 | 279.73M |
| Date | Value |
|---|---|
| September 30, 2019 | 285.92M |
| June 30, 2019 | 271.10M |
| March 31, 2019 | 296.58M |
| December 31, 2018 | 314.06M |
| September 30, 2018 | 293.25M |
| June 30, 2018 | 305.54M |
| March 31, 2018 | 327.78M |
| December 31, 2017 | 340.68M |
| September 30, 2017 | 222.26M |
| June 30, 2017 | 241.05M |
| March 31, 2017 | 257.55M |
| December 31, 2016 | 273.06M |
| September 30, 2016 | 290.62M |
| June 30, 2016 | 300.69M |
| March 31, 2016 | 64.19M |
| December 31, 2015 | 75.82M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
250.26M
Minimum
Mar 2020
1.193B
Maximum
Dec 2022
660.43M
Average
748.69M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna Inc | 8.604B |
| Regeneron Pharmaceuticals Inc | 10.84B |
| NeuroMetrix Inc | 18.00M |
| Repligen Corp | 751.32M |
| Pacific Biosciences of California Inc | 631.42M |